Jim Nightingale - Ph.D.


Jim Nightingale serves as President at Bend Research and Managing Director of the Bend Capsugel site, where he has worked since 1993.  His areas of scientific expertise include the development of pharmaceutical drug-delivery systems, including controlled- and triggered-release formulations and the bioavailability-enhanced formulations for low-solubility compounds.  He was instrumental in the development of Bend Research’s spray-dried dispersion (SDD) and nanoparticle technologies for delivery of low-solubility compounds and has assisted in the application of Bend Research technologies to numerous compounds, ranging from those in preclinical stages to those in Phase 3 trials.  Jim holds a bachelor’s degree in chemical engineering and a master’s degree and doctorate in bioengineering, all from the University of Washington.